Bradley Wargo, DO
Interventional Pain Medicine · Muscle Shoals, ALNPI 1447241021
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $25,218 of the $40,631 with a category attached, or 62.1%. Vertex accounts for 75.2% of it on its own, with 22 other manufacturers making up the rest. 2025 is the largest year on record at $31,294, more than ten times the $347 reported in 2019. Among interventional pain medicine clinicians in AL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 161 payments — averaging $252.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vertex$31K
- Gentleman Orthopedic Solutions$4K
- Arthrex$3K
- Nevro Corp.$1K
- Abbott$868
- Boston Scientific$407
- plus $1K from 17 others
What the payments were for
- Speaking & faculty fees$25,21862%
- Travel & lodging$5,28213%
- Food & beverage$4,54511%
- Education$5,58614%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vertex | 58 | $30,542 |
| Gentleman Orthopedic Solutions | 3 | $3,928 |
| Arthrex | 6 | $2,596 |
| Nevro Corp. | 25 | $1,043 |
| Abbott | 24 | $868 |
| Boston Scientific | 16 | $407 |
| Medtronic | 5 | $261 |
| GRT US Holding, Inc. | 2 | $234 |
| Curonix LLC | 1 | $142 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $138 |
| Stimwave Technologies Incorporated | 1 | $68 |
| Stryker | 3 | $59 |
| Biotronik NRO, Inc. | 2 | $56 |
| SPR Therapeutics, Inc | 2 | $51 |
| Kowa Pharmaceuticals America, Inc. | 2 | $42 |
| Saluda Medical Americas, Inc. | 1 | $35 |
| Relievant Medsystems, Inc. | 1 | $32 |
| Collegium Pharmaceutical, Inc. | 2 | $30 |
| MML US, Inc. | 1 | $24 |
| Nalu Medical, Inc. | 1 | $20 |
| Scilex Pharmaceuticals Inc. | 1 | $20 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $17 |
| Amgen | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$40,631 in reported general payments places this provider in the 95th percentile of 33 interventional pain medicine providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 92 | $1,231 |
| Cephalexin | 15 | $181 |
| Nortriptyline Hcl | 22 | $113 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Muscle Shoals
- Michael KendrickBirmingham$90K
- Jacob VellaMontgomery$28K
- John IronsVestavia$22K
- Richard WebbFoley$18K
- Ryan AlmeidaBirmingham$14K
- Roberto ChangHoover$13K
- Bradley KatzMontgomery$12K
- Thomas MartinHoover$11K
- David HerrickMontgomery$9K
- Aaron ShinklePrattville$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.